Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer|February 27, 2008
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or olderGeorge R Simon, Martine Extermann, Alberto Chiappori, et al.
Cancer|April 23, 2014
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)Gerold Bepler, Ralph G Zinner, James Moon, et al.
Psycho-Oncology|June 21, 2012
Effects of self-directed stress management training and home-based exercise on quality of life in cancer patients receiving chemotherapy: a randomized controlled trialPaul B Jacobsen, Kristin M Phillips, Heather S L Jim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Phase I study of a novel taxane BMS-188797 in adult patients with solid malignanciesChristopher R Garrett, Mayer N Fishman, Randall R Rago, et al.
Cancer Immunology, Immunotherapy : CII|December 29, 2018
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancerAlberto A Chiappori, Charles C Williams, Jhanelle E Gray, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2011
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumorsGeorge R Simon, Robert L Ilaria, Mika A Sovak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2014
A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumorsJhanelle E Gray, Eric Haura, Alberto Chiappori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic studyGeorge R Simon, Christopher R Garrett, Stephen C Olson, et al.
Oncotargets and Therapy|September 19, 2017
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumorsBen C Creelan, Dmitry I Gabrilovich, Jhanelle E Gray, et al.
Cancer|February 3, 2015
Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinibPeter Reichardt, Yoon-Koo Kang, Piotr Rutkowski, et al.
Pageof 3